Trimethylamine NOxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis Liu 2020 Mediators of Inflammation Wiley Online Library TMAO: how gut microbiota contributes to heart failure Translational Research Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link Trimethylamine N oxide (TMAO) is a small molecule produced in humans primarily by the gut liver axis and has become an important biomarker, and possible mediator, of cardiometabolic and renal disease. Dietary choline, phosphatidylcholine ( PDF] Trimethylamine N Oxide, the Microbiome, and Heart and Kidney Disease. Semantic Scholar Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N Oxide